Decaffeinated green coffee bean extract attenuates diet-induced obesity and insulin resistance in mice

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Song, Su Jin ^a   Choi, Sena ^a   Park, Taesun ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALPHA INTERFERON; BETA ACTIN; BETA INTERFERON; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD36 ANTIGEN; CYCLIN D1; DECAFFEINATED GREEN COFFEE BEAN EXTRACT; FATTY ACID SYNTHASE; GALANIN; GALANIN RECEPTOR 1; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLANT EXTRACT; PROTEIN KINASE C BETA; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WNT10B PROTEIN;

ADIPOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; DOWN REGULATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WESTERN BLOTTING; WHITE ADIPOSE TISSUE;

EID: 84900317625     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/718379     Document Type: Article

References (42)

1. Smith A., Effects of caffeine on human behavior. Food and Chemical Toxicology 2002 40 9 1243 1255 2-s2.0-0036710108 10.1016/S0278-6915(02)00096-0 (Pubitemid 35247455)
2. Appel C. C., Myles T. D., Caffeine-induced hypokalemic paralysis in pregnancy. Obstetrics & Gynecology 2001 97 5, part 2 805 807 2-s2.0-0035043403 10.1016/S0029-7844(00)01210-2 (Pubitemid 32406182)
3. Curatolo P. W., Robertson D., The health consequences of caffeine. Annals of Internal Medicine 1983 98 5, part 1 641 653 2-s2.0-0020535487 (Pubitemid 13091178)
4. Cornelis M. C., Coffee intake. Progress in Molecular Biology and Translational Science 2012 108 293 322 10.1016/B978-0-12-398397-8.00012-5
5. Rosso A., Mossey J., Lippa C. F., Caffeine: neuroprotective functions in cognition and Alzheimer's disease. American Journal of Alzheimer's Disease & Other Dementias 2008 23 5 417 422 2-s2.0-54049151578 10.1177/1533317508320083
6. van Dam R. M., Hu F. B., Coffee consumption and risk of type 2 diabetes: a systematic review. The Journal of the American Medical Association 2005 294 1 97 104 2-s2.0-21444448910 10.1001/jama.294.1.97 (Pubitemid 41002844)
7. Greenberg J. A., Boozer C. N., Geliebter A., Coffee, diabetes, and weight control. The American Journal of Clinical Nutrition 2006 84 4 682 693 2-s2.0-33750613195 (Pubitemid 44715648)
8. Tanaka K., Nishizono S., Tamaru S., Kondo M., Shimoda H., Tanaka J., Okada T., Anti-obesity and hypotriglyceridemic properties of coffee bean extract in SD rats. Food Science and Technology Research 2009 15 2 147 152 2-s2.0-66049093215 10.3136/fstr.15.147
9. Murase T., Misawa K., Minegishi Y., Aoki M., Ominami H., Suzuki Y., Shibuya Y., Hase T., Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. American Journal of Physiology: Endocrinology and Metabolism 2011 300 1 E122 E133 2-s2.0-78650762536 10.1152/ajpendo.00441.2010
10. Ho L., Varghese M., Wang J., Zhao W., Chen F., Knable L. A., Ferruzzi M., Pasinetti G. M., Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutritional Neuroscience 2012 15 1 37 45 2-s2.0-84856762872 10.1179/1476830511Y. 0000000027
11. Ong K. W., Hsu A., Tan B. K. H., Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS ONE 2012 7 3 2-s2.0-84857802931 10.1371/journal.pone.0032718 e32718
12. Cho A.-S., Jeon S.-M., Kim M.-J., Yeo J., Seo K.-I., Choi M.-S., Lee M.-K., Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food and Chemical Toxicology 2010 48 3 937 943 2-s2.0-76749122292 10.1016/j.fct.2010.01.003
13. Hemmerle H., Burger H.-J., Below P., Schubert G., Rippel R., Schindler P. W., Paulus E., Herling A. W., Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. Journal of Medicinal Chemistry 1997 40 2 137 145 2-s2.0-0031022886 10.1021/jm9607360 (Pubitemid 27045071)
14. de Sotillo D. V. R., Hadley M., Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. The Journal of Nutritional Biochemistry 2002 13 12 717 726 2-s2.0-0036903553 10.1016/S0955-2863(02)00231-0 (Pubitemid 35463200)
15. Rangwala S. M., Lazar M. A., Transcriptional control of adipogenesis. Annual Review of Nutrition 2000 20 535 559 2-s2.0-0033830783 10.1146/annurev.nutr.20.1.535
16. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 2006 116 11 3015 3025 2-s2.0-33750584214 10.1172/JCI28898 (Pubitemid 44684486)
17. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of Clinical Investigation 2003 112 12 1821 1830 2-s2.0-9144223683 10.1172/JCI200319451 (Pubitemid 38063705)
18. Moon J.-K., Yoo H. S., Shibamoto T., Role of roasting conditions in the level of chlorogenic acid content in coffee beans: correlation with coffee acidity. Journal of Agricultural and Food Chemistry 2009 57 12 5365 5369 2-s2.0-67649224315 10.1021/jf900012b
19. Dellalibera O., Lemaire B., Lafay S., Svetol, green coffee extract, induces weight loss and increases the lean to fat mass ratio in volunteers with overweight problem. Phytotherapie 2006 4 4 194 197 2-s2.0-33751571667 10.1007/s10298-006-0181-7 (Pubitemid 44843813)
20. Reagan-Shaw S., Nihal M., Ahmad N., Dose translation from animal to human studies revisited. The FASEB Journal 2008 22 3 659 661 2-s2.0-40449086665 10.1096/fj.07-9574LSF (Pubitemid 351348146)
21. Zhao Z., Shin H. S., Satsu H., Totsuka M., Shimizu M., 5-caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF- α -induced secretion of interleukin-8 from Caco-2 cells. Journal of Agricultural and Food Chemistry 2008 56 10 3863 3868 2-s2.0-45549103168 10.1021/jf073168d (Pubitemid 351860195)
22. Bassoli B. K., Cassolla P., Borba-Murad G. R., Chlorogenic acid reduces the plasma glucose peak in the oral glucose tolerance test: effects on hepatic glucose release and glycaemia. Cell Biochemistry and Function 2008 26 3 320 328 2-s2.0-42949178642 10.1002/cbf.1444 (Pubitemid 351613172)
23. Christodoulides C., Lagathu C., Sethi J. K., Vidal-Puig A., Adipogenesis and WNT signalling. Trends in Endocrinology & Metabolism 2009 20 1 16 24 2-s2.0-58149252268 10.1016/j.tem.2008.09.002
24. Kim A., Park T., Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice. Molecular Nutrition & Food Research 2010 54 9 1361 1370 2-s2.0-77957094842 10.1002/mnfr.200900317
25. Schulz T. J., Tseng Y.-H., Emerging role of bone morphogenetic proteins in adipogenesis and energy metabolism. Cytokine & Growth Factor Reviews 2009 20 5-6 523 531 2-s2.0-70649109834 10.1016/j.cytogfr.2009.10.019
26. He X., A Wnt-Wnt situation. Developmental Cell 2003 4 6 791 797 2-s2.0-0037604557 10.1016/S1534-5807(03)00165-5 (Pubitemid 36676032)
27. Rauch A., Mandrup S., Lighting the fat furnace without SFRP5. The Journal of Clinical Investigation 2012 122 7 2349 2352 10.1172/JCI64196
28. Gustafson B., Smith U., The WNT inhibitor dickkopf 1 and bone morphogenetic protein 4 rescue adipogenesis in hypertrophic obesity in humans. Diabetes 2012 61 5 1217 1224 2-s2.0-84860591046 10.2337/db11-1419
29. Qi J., Zhu Y.-Q., Luo J., Tao W.-H., Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World Journal of Gastroenterology 2006 12 44 7113 7117 2-s2.0-33845427638 (Pubitemid 44890639)
30. Saar I., Runesson J., McNamara I., Järv J., Robinson J. K., Langel Ü., Novel galanin receptor subtype specific ligands in feeding regulation. Neurochemistry International 2011 58 6 714 720 2-s2.0-79953713956 10.1016/j.neuint.2011.02.012
31. Seta Y., Kataoka S., Toyono T., Toyoshima K., Expression of galanin and the galanin receptor in rat taste buds. Archives of Histology and Cytology 2006 69 4 273 280 2-s2.0-33847001674 10.1679/aohc.69.273
32. Lang R., Gundlach A. L., Kofler B., The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacology & Therapeutics 2007 115 2 177 207 2-s2.0-34447255940 10.1016/j.pharmthera.2007.05.009 (Pubitemid 47042915)
33. Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhangs Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P. A., Friedman J. M., Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1 11 1155 1161 2-s2.0-0028845877
34. Jadeja R. N., Thounaojam M. C., Ramani U. V., Devkar R. V., Ramachandran A. V., Anti-obesity potential of Clerodendron glandulosum. Coleb leaf aqueous extract. Journal of Ethnopharmacology 2011 135 2 338 343 2-s2.0-79955678314 10.1016/j.jep.2011.03.020
35. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance. The Journal of Clinical Investigation 2006 116 7 1793 1801 2-s2.0-33745861300 10.1172/JCI29069
36. Gregor M. F., Hotamisligil G. S., Inflammatory mechanisms in obesity. Annual Review of Immunology 2011 29 415 445 2-s2.0-79953046341 10.1146/annurev-immunol-031210-101322
37. Mittra S., Bansal V. S., Bhatnagar P. K., From a glucocentric to a lipocentric approach towards metabolic syndrome. Drug Discovery Today 2008 13 5-6 211 218 2-s2.0-40949120497 10.1016/j.drudis.2008.01.006
38. Erridge C., Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of Leukocyte Biology 2010 87 6 989 999 2-s2.0-77954005130 10.1189/jlb.1209775
39. Nguyen M. T. A., Satoh H., Favelyukis S., Babendure J. L., Imamura T., Sbodio J. I., Zalevsky J., Dahiyat B. I., Chi N.-W., Olefsky J. M., JNK and tumor necrosis factor- α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. The Journal of Biological Chemistry 2005 280 42 35361 35371 2-s2.0-27444445460 10.1074/jbc.M504611200 (Pubitemid 41532725)
40. Kim J. K., Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metabolism 2006 4 6 417 419 2-s2.0-33751436631 10.1016/j.cmet.2006.11.008 (Pubitemid 44817355)
41. Kim S.-J., Choi Y., Choi Y.-H., Park T., Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. The Journal of Nutritional Biochemistry 2012 23 2 113 122 2-s2.0-84855508991 10.1016/j.jnutbio.2010.10.012
42. Feinstein R., Kanety H., Papa M. Z., Lunenfeld B., Karasik A., Tumor necrosis factor- α suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. The Journal of Biological Chemistry 1993 268 35 26055 26058 2-s2.0-0027332738